rTMS-augmented Written Exposure Therapy for PTSD
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Post Traumatic Stress Disorder
In brief
Post-traumatic stress disorder (PTSD) is prevalent and represents a high healthcare burden among Veterans. Repetitive transcranial magnetic stimulation (rTMS) is a brain-based therapy that may be effective for treating PTSD. The theorized mechanism of rTMS is enhancement of emotional flexibility via the dorsolateral prefrontal cortex node of the brain's cognitive control network. Given this mechanism of action, adding rTMS to an evidence-based psychotherapy (EBP) for PTSD may enhance treatment effects. Written exposure therapy (WET) is a brief EBP for PTSD found to reduce attrition compared to lengthier first line treatments. In this study, the investigators will determine if active rTMS added to WET compared with sham rTMS added to WET results in improved PTSD outcomes. The investigators will also determine if emotional flexibility is a mechanism of symptom improvement. This work will improve upon PTSD intervention and inform the mechanism of treatment effectiveness for Veterans suffering from PTSD.
Key facts
- Study ID
- NCT05149534
- Run by
- VA Office of Research and Development
- People needed
- 98
- Starts
- 2022-01-03
- Expected to finish
- 2027-01-29
- Last updated by the study team
- 2026-01-12
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All veterans are eligible to be included in the study if they meet all the following criteria:
- veteran;
- English-speaking and able to provide written informed consent;
- diagnosed with PTSD;
- between the ages of 18 and 60 years. Participants over age 60 will not be included, as aging is known to impact brain structure, and thus the potential accuracy of the rTMS target, independently of PTSD.
You may not qualify if…
- Individuals with history of seizures or other serious neurological history including acquired, developmental or degenerative neurologic illness, identified through medical chart review, will be excluded due to potential lowered threshold for seizures during rTMS stimulation.
- The effects of rTMS are unknown on fetal development, therefore, women who are pregnant will be excluded.
- Participants will also be screened and excluded if any of the following are met:
- current psychosis including psychotic disorder,
- bipolar disorder,
- schizophrenia; or another severe cognitive or psychiatric disorder;
- positive screen for current suicidal intent and plan [with a score of 2 or 3 on BDI-2 item 9];
- current substance use disorder; or substance use in the last 12 hours before the rTMS session.
- The investigators note that PTSD is often comorbid with traumatic brain injury (TBI) in military veterans who were deployed to a war zone. The investigators will use the Department of Defense and Veterans Affairs consensus-based classification of TBI severity for classification of TBI.
- Participants with moderate or severe TBI will be excluded.
- Participants with mild traumatic brain injury (mTBI) or concussion will be enrolled. This will enhance the ecological validity of the study.
- Participants with cognitive impairment as evidenced by a Montreal Cognitive Screen (MoCA) less than 23/30 or estimated baseline intellectual ability of a standard score of less than 80 on a word reading test will be excluded due to potential neurocognitive differences.
- Participants on psychotropic medications will not be excluded, but participants will be required to be stable on their medication for at least four weeks prior to beginning the study and throughout the time of study.
- Participants enrolled in long term, supportive psychotherapy (i.e. not an evidence-based psychotherapy (EBP)) may continue to be involved in their treatment throughout the study. However, participants involved in a concurrent EBPs will be excluded. Participants will be asked to disclose whether they chose to participate in an EBP during the course of the treatment or followup phases of the study.
Where it is running
- Central Texas Veterans Health Care System, Temple, TX — Temple, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.